Just heard today on TV lunch-time news in UK that Gabapentin and Pregabalin are to be classified as Class C controlled substances from today, 1st April 2019 mainly as a result of gross misuse causing deaths most prevalently in Scotland.
One would imagine such classification will result in fewer doctors prescribing these drugs generally in future due to Class restrictions. The drugs are not being withdrawn so will still be available for existing patients.
The restrictions mean, and here I quote:
prescriptions of Pregabalin and Gabapentin will also be limited to 30 days’ treatment and repeat prescriptions will not be issued. Any prescription received must be dispensed within 28 days.
Apparently due to the classification pharmacists will not be able to accept electronic prescriptions for these drugs.
How this reclassification will affect UK residents taking these drugs for MAV Long-term I don’t know but there’s no mention of the drugs being withdrawn. Presumably users need to check it out with their GP. Helen